These lab-created options were not designed with recreational use in your mind. While in the 1990s, John W. Huffman and a workforce of fellow chemists at Clemson College created some of the very first formulation for artificial cannabinoid receptor agonists (SCRAs), a relatives of substances that imitate the physiological and psychological impacts